Toby Maher
@TobyMMaher
Director of ILD @KeckMedUSC. @asthmalunguk Prof of Respiratory Research, @imperialNHLI Prof of Interstitial Lung Disease and #IPF doctor. Working to #cureIPF
ID:535472221
https://profiles.sc-ctsi.org/toby.maher 24-03-2012 16:06:43
713 Tweets
3,2K Followers
529 Following
Follow People
Naftali Kaminski
First Generation Physician-Scientist, & many other things. This account is Private - opinions and tweets do not represent any of the organizations I work with.
Gisli Jenkins
NIHR Research Professor. Margaret Turner Warwick Chair of Thoracic Medicine. Imperial College London. President @ActionPFcharity. #Cycling #COYS #CureIPF
British Thoracic Society (BTS)
The British Thoracic Society is the largest respiratory membership body in the UK. We work towards better lung health for all. Our tweets are not endorsements.
ERS publications
European Respiratory Journal, European Respiratory Review, ERJ Open Research, Breathe, the ERS Monograph and ERS Handbooks, and European Lung White Book
Kerri Johannson MD MPH
Physician. Interstitial Lung Disease. Environmental Health. Feminism. Human Rights. She/Her. May All Beings Be Happy.
Director of the interstitial lung disease unit at Keck Medicine of USC Toby Maher discusses the diagnosis and management of interstitial lung disease with JAMA Deputy Editor Mary McGrae McDermott. ja.ma/3Uu3LQX
So excited to see Dr. Paul Noble, a superb member & leader of the #CurePF4All community, take over as President of the Association of American Physicians !!!
Well deserved, Paul, and great for all of us!!!
👏🏼👏🏼👏🏼Paul Noble Cedars-Sinai👏🏼👏🏼👏🏼
Predicting progressive disease and mortality in IPF using automated analysis of CT scans. A massive collaborative effort between NHLI Qureight & AstraZeneca now in press ATS Blue Journal #cureipf
atsjournals.org/doi/abs/10.116…
Great example of value of patient registries, machine learning & proteomics in Interstitial Lung Disease! 'Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease'. Kudos Drs Huang, Ma, Martnez, Noth & teams!
#Biomarkers
atsjournals.org/doi/10.1164/rc…
Low dose oral Morphine is safe and effective for IPF-related cough 👇👇
Kudos Phil Molyneaux and team for this important patient-focused work!!
Pilar Rivera-Ortega ILD IPF Doc: Nazia Chaudhuri Toby Maher Muhunthan Thillai
🧬 Dive into the 4TH International Symposium on Interstitial Lung Disease in Rheumatic Diseases
👩💻 Participation is completely 🆓
Go to this Link: internationalild.ch
Dr. Dinesh Khanna Lorenzo Cavagna vincent cottin didier phillippe Toby Maher Friends of World Scleroderma Foundation
prnewswire.com/news-releases/… Excited to launch the CONQUEST SRFCure Toby Maher U-M Department of Internal Medicine
1/n
Finally out! The 'Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, TLF, and PFF Workshop Report'!
With discussions & recommendations for:
- novel models & research tools
- Early disease
- Innovative clinical trial designs
#CurePFWorkshop
atsjournals.org/doi/abs/10.116…
Happy Thanksgiving! SAVE THE DATE. Free registration coming soon Friends of World Scleroderma Foundation Congresso Reuma Pavia 09/23 Jeffrey Sparks MD MMSc World Scleroderma Foundation Toby Maher Vincent Cottin Elana J. Bernstein, MD, MSc
Dr. Kathleen Lindell Pulmonary Fibrosis Foundation Jamie Lederer Jose D. Herazo-Maya Lori Reed Third session of the day for fellows and community pulmonologists: transplant, clinical trials, and palliative care. #PFFSummit2023
Finally out! “Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena - An Official American Thoracic Society Report! Kudos to fearless & unstoppable leaders Milica Vukmirovic Louise Hecker & team!!
#Innovation #RCMBRocks
Very pleased to share work from my PhD with Lloyd Lab NHLI Toby Maher Adam Byrne published in Nature Communications . Here, we show how changes in the extracellular matrix in IPF influence the distribution and migration of KRT5+ basal cells. #CureIPF nature.com/articles/s4146…
🔴 #ERSCongress 2023 :
Luca Richeldi Università Cattolica discute l’effet du #BI1015550 dans #FPI - étude randomisée #Phase2 :
- prévient déclin #CVF à 12 semaines
- effet limité du traitement sur l'expression des gènes 🧬 ⤵️
Toby Maher Vincent Cottin
📢 Our latest #WIN podcast is out now!
🎙 PA Juge & Philipp Bosch
are joined by Toby Maher
to discuss the #RECITAL trial
👉 Read the paper: thelancet.com/journals/lanre…
🎧 Listen to the interview: pulse.ly/4clvgsi541
Today, the Scleroderma Research Foundation is announcing the launch of CONQUEST, an innovative platform clinical trial designed to rapidly advance #scleroderma treatments. Read more: bit.ly/3KmGFGe
We're grateful to Dr. Dinesh Khanna and Toby Maher for their partnership.
Delighted to partner with SRFCure and Toby Maher to launch the first platform trial in #scleroderma #ILD U-M Department of Internal Medicine businesswire.com/news/home/2023…
